Partial left ventriculectomy in patients with neoplasms and severe heart failure who are not candidates for cardiac transplantation [3]

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 1, 2004, Pages 302-303

  Christiansen, Stefan ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN;

ANIMAL MODEL; CANCER CHEMOTHERAPY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEALTH CARE COST; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HEMODYNAMIC PARAMETERS; HUMAN; INTRACORONARY INFUSION; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; PARTIAL LEFT VENTRICULECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR;

EID: 0742288424     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.06.014     Document Type: Letter

References (4)

1. Casarotto D, Bottio T, Gambino A, Testolin L, Gerosa G. The last to die is hope: prolonged mechanical circulatory support with a Novacor left ventricular assist device as a bridge to transplantation. J Thorac Cardiovasc Surg. 2003;125:417-8.
2. Shah HR, Vaynblat M, Ramdev G, Cunningham JN, Chiavarelli M. Experimental cardiomyopathy as a model of chronic heart failure. J Invest Surg. 1997;10:387-96.
3. Christiansen S, Redmann K, Scheld HH, Jahn UR, Stypmann J, Fobker M, et al. Adriamycin-induced cardiomyopathy in the canine-an appropriate model for research on partial left ventriculectomy? J Heart Lung Transplant. 2002;21:783-90.
4. Christiansen S, Stypmann J, Jahn UR, Redmann K, Fobker M, Gruber AD, et al. Partial left ventriculectomy in the modified adriamycin-induced cardiomyopathy in the dog. J Heart Lung Transplant. 2003;22:301-8.